Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioXcel Therapeutics, Inc. - Common Stock
(NQ:
BTAI
)
0.0739
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioXcel Therapeutics, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against BioXcel Therapeutics, Inc. (BTAI)
July 10, 2023
From
Robbins LLP
Via
Business Wire
BTAI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that BioXcel Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the BioXcel Class Action Lawsuit
July 10, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Analyst Expectations for BioXcel Therapeutics's Future
↗
June 30, 2023
Via
Benzinga
EQUITY ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – BTAI
July 10, 2023
From
Rosen Law Firm
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of BioXcel Therapeutics, Inc. (BTAI) Investors
July 10, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
BTAI CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against BioXcel Therapeutics, Inc.
July 08, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BioXcel Therapeutics, Inc. (BTAI) Investors
July 07, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
BTAI CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against BioXcel Therapeutics, Inc.
July 07, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 07, 2023
Via
Benzinga
Why BioXcel Therapeutics Stock Was Bouncing Back This Week
↗
July 07, 2023
What a difference a handful of trading days has made for the company.
Via
The Motley Fool
Levi Strauss, Riot Platforms And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
July 07, 2023
U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Affirm Holdings, Applied Digital And Other Big Stocks Moving Lower On Thursday
↗
July 06, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 450 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
July 06, 2023
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Via
InvestorPlace
Perion Network And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
↗
July 06, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 05, 2023
Via
Benzinga
BioXcel Therapeutics Inc. (NASDAQ: BTAI) Near the Top of Equities by Percentage Gain on 7/5
July 05, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Dow Drops 150 Points; US Factory Orders Increase 0.3% In May
↗
July 05, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.46% to 34,259.45 while the NASDAQ fell...
Via
Benzinga
Wells Fargo To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday
↗
July 03, 2023
Jefferies boosted the price target for ACM Research, Inc. (NASDAQ: ACMR) from $9 to $23.4. Jefferies analyst Nick Cheng upgraded the stock from Underperform to Buy. ACM Research shares fell 2.2% to...
Via
Benzinga
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
July 05, 2023
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...
Via
Benzinga
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
↗
June 30, 2023
Major indexes rebounded strongly and many stocks flashed buy signals.
Via
Investor's Business Daily
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of BioXcel Therapeutics, Inc. (BTAI) on Behalf of Investors
June 30, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of BioXcel Therapeutics, Inc. (BTAI) on Behalf of Investors
June 30, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against BioXcel Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
June 30, 2023
From
The Schall Law Firm
Via
Business Wire
Lost Money in BioXcel Therapeutics, Inc? Gibbs Law Group Investigates Potential Securities Law Violations
June 29, 2023
From
Gibbs Law Group
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BioXcel Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
June 29, 2023
From
The Schall Law Firm
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of BioXcel Therapeutics, Inc. (BTAI) on Behalf of Investors
June 29, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates
↗
June 29, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.68% to 34,081.83 while the NASDAQ fell 0.23% to 13,560.57. The S&P...
Via
Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
June 29, 2023
Via
Benzinga
Dow Up Triple Digits After Bank Stress Test, GDP Revision
↗
June 29, 2023
The Dow Jones Industrial Average is up 194 points midday, while the S&P 500 Index and Nasdaq Composite move cautiously higher.
Via
Talk Markets
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
